CD3×CD20 Bispecific Toxicities and Consensus Recommendations for Managing

Opinion
Video

Panelists discuss how to operationalize bispecific antibody (BsAb) therapy in community practices, summarizing the toxicities associated with CD3×CD20 BsAbs and presenting consensus recommendations for their management.

Video content above is prompted by the following:

  1. This presentation is to do a deep dive into the operationalization of bispecific antibody (BsAb) therapy in community practices.
  • Please summarize the toxicities observed with CD3×CD20 BsAbs.

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Recent Videos
Related Content